Compare · head to head
Hansoh Pharmaceutical vs HUTCHMED (China)
Hansoh Pharmaceutical ranks higher overall — 360 rank 66 vs 27.
HUTCHMED (China) leads on Value (54 vs 37). Hansoh Pharmaceutical leads on Quality (59 vs 42), Growth (50 vs 41), Safety (69 vs 44) and Sentiment (50 vs 44).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Hong Kong SAR China | Hong Kong SAR China |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Large | Medium |
| ISIN | KYG549581067 | KYG4672N1198 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 66 | 27 |
| Value | 37 | 54 |
| Quality | 59 | 42 |
| Growth | 50 | 41 |
| Safety | 69 | 44 |
| Sentiment | 50 | 44 |
| Quality details | ||
| Profitability | 71 | 48 |
| Cash Truth | 48 | 36 |
Hansoh Pharmaceutical vs Takeda PharmaceuticalHansoh Pharmaceutical vs CSPC PharmaceuticalHansoh Pharmaceutical vs Aprogen BiologicsHansoh Pharmaceutical vs Dongwha PharmAdd a third stock →
Full analyses: Hansoh Pharmaceutical · HUTCHMED (China)
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100